Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis

Journal of Basic Microbiology

Volumn 48, Issue 3, 2008, Pages 202-206

  Bratkovič, Tomaž ^a,b   Lunder, Mojca ^b   Urleb, Uroš ^a,b   Štrukelj, Borut ^b  

^a Lek Pharmaceutical Company   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cell wall biosynthesis; Mur ligase; Peptide inhibitor; Peptidoglycan; Phage display

Indexed keywords

BACTERIA (MICROORGANISMS);

ANTIINFECTIVE AGENT; ENZYME INHIBITOR; PEPTIDE LIBRARY; PEPTIDE SYNTHASE; PEPTIDOGLYCAN;

ARTICLE; BIOSYNTHESIS; CELL WALL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; ESCHERICHIA COLI; METABOLISM; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL WALL; ENZYME INHIBITORS; ESCHERICHIA COLI; PEPTIDE LIBRARY; PEPTIDE SYNTHASES; PEPTIDOGLYCAN; STAPHYLOCOCCUS AUREUS;

EID: 47649112998     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.200700133     Document Type: Article

References (19)

1. Projan, S.J., 2002. New (and not so new) antibacterial targets - from where and when will the novel drugs come? Curr. Opin. Pharmacol., 2, 513-522.
2. Su, Z. and Honek, J.F., 2007. Emerging bacterial enzyme targets. Curr. Opin. Invest. Drugs, 8(2), 140-149.
3. Koch, A.L., 2003. Bacterial wall as target for attack: past, present, and future research. Clin. Microbiol. Rev., 16(4), 673-687.
4. Bernhardt, T.G., Wang, I.N., Struck and D.K., Young, R., 2001. A protein antibiotic in the phage Qbeta virion: diversity in lysis targets. Science, 292, 2326-2329.
5. Kimura, K., Ikeda, Y., Kagami, S, Yoshihama, M. et al., 1998. Selective inhibition of the bacterial peptidoglycan synthesis by the new types of liposidomycins. J. Antibiot., 51, 1099-1104.
6. El Zoeiby, A., Sanschagrin, F. and Levesque, R.C., 2003. Structure and function of the Mur enzymes: development of novel inhibitors. Mol. Microbiol., 47(1), 1-12.
7. Green, D.W., 2002. The bacterial cell wall as a source of antibacterial targets. Expert Opin. Ther. Targets, 6(1), 1-19.
8. Katz, A.H. and Caufield, C.E., 2003. Structure-based design approaches to cell wall biosynthesis inhibitors. Curr. Pharm. Des., 9, 857-866.
9. Silver, L.L., 2006. Does the cell wall of bacteria remain a viable source of targets for novel antibiotics? Biochem. Pharmacol., 71, 996-1005.
10. El Zoeiby, A., Sanschagrin, F., Darveau, A., Brisson, J.-R. and Levesque, R.C., 2003. Identification of novel inhibitors of Pseudomonas aeruginosa MurC enzyme derived from phage-displayed peptide libraries. J. Antimicrob. Chemother., 51, 531-543.
11. Paradis-Bleau, C., Beaumont, M., Boudreault, L., Lloyd, A. et al., 2006. Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme. Peptides, 27(7), 1693-1700.
12. Smith, G.P. and Petrenko, V.A., 1997. Phage display. Chem. Rev., 97, 391-410.
13. Smith, C.A., 2006. Structure, function and dynamics in the mur family of bacterial cell wall ligases. J. Mol. Biol., 362, 640-655.
14. Bertrand, J.A., Fanchon, E., Martin, L., Chantalat, L. et al., 2000. 'Open' structures of MurD: Domain movements and structural similarities with folylpolyglutamate synthetase. J. Mol. Biol., 301, 1257-1266.
15. Grøn, H. and Hyde-DeRuyscher, R., 2000. Peptides as tools in drug discovery. Curr. Opin. Drug Discov. Dev., 3, 636-645.
16. Lowman, H.B., 1997. Bacteriophage display and discovery of peptide leads for drug development. Annu. Rev. Biomol. Struct., 26, 401-424.
17. Paradis-Bleau, C., Sanschagrin, F. and Levesque, R.C., 2004. Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for the development of novel antimicrobials. J. Antimicrob. Chemother., 54(1), 278-280.
18. Paradis-Bleau, C., Sanschagrin, F. and Levesque, R.C., 2005. Peptide inhibitors of the essential cell division protein FtsA. Protein Eng. Des. Select., 18(2), 85-91.
19. Falciani, C., Lozzi, L., Pini, A. and Bracci, L., 2005. Bioactive peptides from libraries. Chem. Biol., 12, 417-426.